Corporate overview

Company name Bonac Corporation
Co-founder and Chairman Tadaaki Ohgi, Ph.D.
President and CEO Hirotake Hayashi
Director Kihito Takahashi, M.D., Ph.D., MBA
Kyoko Miyoshi, M.Sc.
Masahiko Kuroda, M.D., Ph.D. (Tokyo Medical University, Department of Molecular Pathology Professor & Chairman, Part-time)
Takeo Kitayama (SUMITOMO CHEMICAL Co., Ltd., Associate Officer, External Director)
Philippe Fauchet, OBE (External Director)
Yoshihiko Okamoto (Koei Chemical Co., Ltd., Advisor, External Director)
Yoshihiko Matsuo (Audit and Supervisory Committee Member, External Director)
Yoshiro Hori (Audit and Supervisory Committee Member, External Director)
Tokuichiro Ide (Audit and Supervisory Committee Member, External Director)
Executive officer Nobuhiro Noro, Ph.D.
Date of establishment February 2010
Capital 3,877million yen (As of the end of December, 2017)
Business RNA therapeutics
Patent license
Technology consulting
Head Office Fukuoka Bio Factory, 1488-4 Aikawa, Kurume Fukuoka 839-0861, JAPAN
TEL: 81-942-32-6700 FAX: 81-942-32-4611
Fukuoka Branch Shin-KBC Building 8th Floor 1-1-35 Nagahama, Chuou-ku, Fukuoka, 810-0072, JAPAN
TEL: 81-92-713-8801 FAX: 81-92-713-8802
Tokyo Branch The fifth Ujiie Building ♯502, 2-16-8,Uchikanda,Chiyoda-ku,Tokyo 101-0047,JAPAN
TEL: 81-3-6206-8604 FAX: 81-3-6206-8704

ページ上部へ